Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-303 in Cataract Surgery
NCT01576952Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Jul 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bromfenac sodium in ocular inflammation, sponsored by Sun Pharma. Started Jul 2012; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01576952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576952.